at Pennsylvania State University

Research Overview
       
   Andrews' group research is centered on the chemistry of the serotonin neurotransmitter system. The primary goal is to understand more fully the role of serotonin in complex behavior, and the etiology and treatment of psychiatric disorders (depression and anxiety disorders). Genetically engineered mice, as well as selective drugs and neurotoxins are used as tools to investigate normative behavior and disease processes. Neurochemistry in these model systems is interrogated using bioanalytical techniques including high-speed carbon fiber microelectrode voltammetry and in vivo microdialysis coupled to high performance liquid chromatography with electrochemical detection.
    Additionally, 
ELISA, RT-qPCR, autoradiography, and immunocytochemistry and  are used to investigate neuroadaptive changes in neuronal innervation and the expression of key proteins such as brain-derived neurotrophic factor (BDNF).
     Neurotransmitter-functionalized self-assembled monolayer “neurochips” have recently been designed for the development of novel in vivo nanobiosensors and functionally-directed proteomics
.

anne andrews research overview in venn diagram
Research Projects Techniques used Group members
Alteration in Serotonin Neurotransmission in Depression and Anxiety disorders Fast cyclic voltammetry, in vivo Microdialysis, Chronoamperometry, Quantitative RT-PCR, Behavioral tests Amanda, YogeshBrendan
BDNF and Neurogenesis Immunocytochemistry, Quantitative RT-PCR, Behavioral tests AmandaMoeTracy, Devashree, Stefanie

 Neurochip for in vivo biosensing and proteomics

QCM, SPR, Fluorescence spectroscopy and microscopy, AFM, FT-IR and Ellipsometry Mitch, Amit
               201 Life Science Building, University Park, PA 16801          |  ©2005 Kaycee Hulet   ©2006 Yogesh Singh


Penn State Home